Sprucegrove Investment Management Ltd. increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,722,350 shares of the pharmacy operator’s stock after purchasing an additional 54,500 shares during the quarter. Walgreens Boots Alliance makes up 3.7% of Sprucegrove Investment Management Ltd.’s holdings, making the stock its 6th largest position. Sprucegrove Investment Management Ltd. owned 0.31% of Walgreens Boots Alliance worth $149,457,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently modified their holdings of WBA. Charter Oak Capital Management LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter valued at about $27,000. Krane Funds Advisors LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter valued at about $28,000. Bogart Wealth LLC raised its stake in Walgreens Boots Alliance by 280.1% in the first quarter. Bogart Wealth LLC now owns 517 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 381 shares during the last quarter. Hexagon Capital Partners LLC raised its stake in Walgreens Boots Alliance by 6,641.7% in the fourth quarter. Hexagon Capital Partners LLC now owns 809 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 797 shares during the last quarter. Finally, Glassman Wealth Services raised its stake in Walgreens Boots Alliance by 181.8% in the first quarter. Glassman Wealth Services now owns 651 shares of the pharmacy operator’s stock valued at $36,000 after buying an additional 420 shares during the last quarter. Hedge funds and other institutional investors own 55.84% of the company’s stock.
Walgreens Boots Alliance stock traded down $0.05 during midday trading on Friday, hitting $55.26. 54,638 shares of the company were exchanged, compared to its average volume of 5,904,397. The company has a market cap of $47.77 billion, a price-to-earnings ratio of -80.16, a PEG ratio of 1.64 and a beta of 0.47. Walgreens Boots Alliance, Inc. has a fifty-two week low of $33.36 and a fifty-two week high of $57.05. The stock’s fifty day simple moving average is $54.08. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.83 and a quick ratio of 0.56.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 11th. Shareholders of record on Friday, May 21st will be issued a $0.4675 dividend. This represents a $1.87 annualized dividend and a yield of 3.38%. The ex-dividend date of this dividend is Thursday, May 20th. Walgreens Boots Alliance’s payout ratio is currently 39.45%.
A number of research firms have commented on WBA. Mizuho increased their price target on Walgreens Boots Alliance from $47.00 to $55.00 and gave the company a “neutral” rating in a research note on Wednesday, May 12th. They noted that the move was a valuation call. Truist Financial increased their price objective on Walgreens Boots Alliance from $50.00 to $58.00 in a report on Thursday, April 1st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Walgreens Boots Alliance in a report on Wednesday. TheStreet raised Walgreens Boots Alliance from a “c” rating to a “b-” rating in a report on Wednesday, March 31st. Finally, Barclays increased their price objective on Walgreens Boots Alliance from $47.00 to $55.00 and gave the company an “equal weight” rating in a report on Monday, April 5th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. Walgreens Boots Alliance presently has an average rating of “Hold” and an average price target of $49.53.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.